Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 16293840.
- Also identified by PMC identifier 1285099.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To study the long term risk of cervical and other cancers after treatment for cervical intraepithelial neoplasia. Retrospective cohort study. University Hospital, Helsinki, Finland. 7564 women treated for cervical intraepithelial neoplasia during 1974 and 2001 and followed up through the Finnish cancer registry until 2003. Standardised incidence ratio for cervical cancer and other cancers. During follow-up 22 cases of invasive cervical cancer occurred in women treated for cervical intraepithelial neoplasia (standardised incidence ratio 2.8, 95% confidence interval 1.7 to 4.2). The highest risk was during the second decade (10 cases observed: 3.1, 1.5 to 5.7). The standardised incidence ratio for cervical intraepithelial cancer type 1 was 3.1 (1.4 to 6.2) and for type 2 was 3.7 (0.9 to 10.7). The risk of cervical cancer in the first 20 years after treatment for cervical intraepithelial neoplasia is higher than in the average population. The risk of smoking related cancers is also increased.
Medical subject headings
- Neoplasm Recurrence, Local
- Neoplasms, Second Primary
- Precancerous Conditions
- Uterine Cervical Neoplasms
- Uterine Cervical Dysplasia